Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 3/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.47 |
| ▸ | DPP4 | P27487 | 2/20 | 0.46 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.46 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.46 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.46 |
| ▸ | AKT1 | P31749 | 1/20 | 0.42 |
| ▸ | TGM2 | P21980 | 1/20 | 0.42 |
| ▸ | CTSS | P25774 | 2/20 | 0.41 |
| ▸ | CTSK | P43235 | 2/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10074723 | 1.00 | ITGB3 (0.47) | ITGB3ITGA2BDPP4DPP8DPP9 | |
| SCHEMBL10077069 | 0.92 | DPP4 (0.49) | ITGB3ITGA2BDPP4DPP8DPP9 | |
| SCHEMBL10054396 | 0.92 | DPP4 (0.49) | ITGB3ITGA2BDPP4DPP8DPP9 | |
| SCHEMBL10074146 | 0.92 | DPP4 (0.49) | ITGB3ITGA2BDPP4DPP8DPP9 | |
| SCHEMBL10074994 | 0.89 | DPP4 (0.46) | ITGB3ITGA2BDPP4DPP8DPP9 | |
| SCHEMBL10077056 | 0.89 | DPP4 (0.46) | ITGB3ITGA2BDPP4DPP8DPP9 | |
| SCHEMBL10054405 | 0.89 | DPP4 (0.46) | ITGB3ITGA2BDPP4DPP8DPP9 | |
| SCHEMBL10078256 | 0.89 | DPP4 (0.46) | ITGB3ITGA2BDPP4DPP8DPP9 | |
| SCHEMBL10074731 | 0.89 | SIRT5 (0.41) | ITGB3ITGA2BDPP4DPP8DPP9 | |
| SCHEMBL10054406 | 0.89 | DPP4 (0.48) | ITGB3ITGA2BDPP4DPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120028995-A1 | NOVEL COMPOUNDS FOR MEDICAL USE AS PEPTIDASE EFFECTORS | IMTM GMBH (DE) | 2012-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120028995-A1 | NOVEL COMPOUNDS FOR MEDICAL USE AS PEPTIDASE EFFECTORS | SERPINB1, CMA1, CPA3 | ITGB3 4136/4885ITGA2B 3392/4885DPP4 121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.